Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
1

Summary

Conditions
  • Hepatocellular Carcinoma
  • Solid Tumor, Adult
Type
Interventional
Phase
Phase 2
Design
Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 99 years
Gender
Both males and females

Description

Assessing side effects and treatment efficacy after injection of drug-eluting microspheres into malignant tumors

Assessing side effects and treatment efficacy after injection of drug-eluting microspheres into malignant tumors

Tracking Information

NCT #
NCT04770207
Collaborators
Not Provided
Investigators
Principal Investigator: Zhenfeng Zhang, MD, PhD Second Affiliated Hospital of Guangzhou Medical University